The role of right heart catheterization prior to initiation of PAH specific therapy

F. Gavilanes, J. L. Alves-Jr., C. Fernandes, C. Jardim, L. Kato, S. Hoette, A. Hovnanian, B. Dias, R. Souza (Sao Paulo, Brazil)

Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Session: Pulmonary circulation: clinical pulmonary hypertension I
Session type: Thematic Poster Session
Number: 2624
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Gavilanes, J. L. Alves-Jr., C. Fernandes, C. Jardim, L. Kato, S. Hoette, A. Hovnanian, B. Dias, R. Souza (Sao Paulo, Brazil). The role of right heart catheterization prior to initiation of PAH specific therapy. Eur Respir J 2013; 42: Suppl. 57, 2624

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Right ventricular function changes after therapy in chronic thromboembolic pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016

Assessment of pulmonary hypertension in lung transplantation candidates; correlation of doppler echocardiography with right heart catheterization
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016


Pulmonary hypertension
Source: Eur Respir Rev 2013; 22: 20-25
Year: 2013



Macitentan reduces the risk of morbidity and mortality irrespective of the presence or absence of right ventricular (RV) impairment: Results from the randomised SERAPHIN trial in pulmonary arterial hypertension (PAH)
Source: International Congress 2014 – Pulmonary hypertension: improving treatment in PAH
Year: 2014


Heart rate recovery in response to disease targeted therapy in pre-capillary pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016


mir-126 contribute to angiogenesis defect in pulmonary arterial hypertension right ventricle failure
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014

Pulmonary vascular reactivity in pulmonary hypertension due to left heart disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Afterload reduction governs improvement in RV systolic function and ventriculo-arterial adaptation in patients with pulmonary arterial hypertension (PAH) undergoing rapid dose escalation of treprostinil
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014

The different nature of pulmonary vascular resistant and compliance in reduced and preserved ejection fraction heart failure and associated pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange
Year: 2014


About cardiac output assessment in pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013

Pregnancy outcomes in pulmonary arterial hypertension in the modern management era},
Source: Eur Respir J 2012; 40: 881-885
Year: 2012



Macitentan for pulmonary arterial hypertension (PAH): Early clinical experience of 94 patients
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015


Chronic thromboembolic pulmonary hypertension: role of medical therapy
Source: Eur Respir J 2013; 41: 985-990
Year: 2013



The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2012; 39: 589-596
Year: 2012



Impact of timing on right heart catheterization measurements in pulmonary hypertension
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020


Pulmonary Function and response to treatment in pulmonary arterial hypertension (PAH)
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016

Right ventricular function and exercise capacity in response to successful pulmonary endarterectomy surgery
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016


Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011



Evaluation of pulmonary hypertension by right heart catheterisation: does timing matter?
Source: Eur Respir J, 56 (3) 1901892; 10.1183/13993003.01892-2019
Year: 2020



The effect of treatment on right ventriculo-arterial coupling in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013